The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
A study published in Cell Metabolism looks at the artificial sweetener aspartame, insulin levels and blood inflammation in mice. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary ...
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
In animal studies, researchers at Karolinska Institutet have found a possible mechanism for how the artificial sweetener ...
Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...